JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, J. P.
Right arrow Articles by Lambert, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, J. P.
Right arrow Articles by Lambert, D. G.
Related Collections
Right arrow Cardiovascular
Right arrow Regional Anesthesia
Right arrow Pharmacology

Anesth Analg 2003;97:1501-1503
© 2003 International Anesthesia Research Society


NEUROSURGICAL ANESTHESIA

A Comparison of Cerebrospinal Fluid and Plasma Urotensin II Concentrations in Normotensive and Hypertensive Patients Undergoing Urological Surgery During Spinal Anesthesia: A Pilot Study

Jonathan P. Thompson, MD FRCA, Philip Watt, FRCA, Sunita Sanghavi, FRCA, James W. Strupish, BSc, and David G. Lambert, PhD

University Department of Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester, United Kingdom

Address correspondence and reprint requests to D. G. Lambert, PhD, University Department of Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester, LE1 5WW, UK. Address e-mail to DGL3{at}le.ac.uk

Urotensin II is a novel endogenous vasoconstrictor. There are no data describing cerebrospinal fluid (CSF) concentrations in humans. Therefore, in this study, we aimed to quantify and compare plasma and CSF urotensin II concentrations in patients with essential hypertension and matched controls. Twenty male patients (10 receiving >6 mo of treatment for essential hypertension and 10 normotensive controls scheduled to undergo urological surgery under spinal anesthesia) were recruited into this single-blinded cohort study. Plasma and CSF urotensin II concentrations were measured by radioimmunoassay, along with mean arterial blood pressure (MAP), before admission, on the day of admission, and immediately before anesthesia. CSF and plasma urotensin II concentrations were low. Median (range) values in CSF for all 20 patients were significantly lower than plasma by ~15% (19.0 pg/mL [10.6–24.9 pg/mL] compared with 22.3 pg/mL [17.7–28.4 pg/mL]; P = 0.004). There were no significant differences between normotensive and hypertensive patients in either CSF or plasma concentrations. However, there was a significant positive correlation between average MAP and CSF urotensin II concentrations (r2 = 0.44; P = 0.036) in the hypertensive group.

IMPLICATIONS: Urotensin II is the most potent known endogenous human vasoconstrictor. In this pilot study, we report for the first time that cerebrospinal fluid levels are smaller than plasma levels and that there may be some association with increased blood pressure.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. D. Leonard, J. P. Thompson, E. L. Hutchinson, S. P. Young, J. McDonald, J. Swanevelder, and D. G. Lambert
Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease
Br. J. Anaesth., April 1, 2009; 102(4): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. E. S. Abdel-Razik, R. J. Balment, and N. Ashton
Enhanced renal sensitivity of the spontaneously hypertensive rat to urotensin II
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1239 - F1247.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
E. Cowley, J. P. Thompson, P. Sharpe, J. Waugh, N. Ali, and D. G. Lambert
Effects of pre-eclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study
Br. J. Anaesth., October 1, 2005; 95(4): 495 - 499.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.